Skip to Content
Home > Care & Treatment > Payson Center for Cancer Care > Clinical Trials > Clinical Trials Search Results
To determine if the addition of Armodafinil will help reduce patient's reported fatigue associated with chemotherapy and radiation therapy.
This trial studies the side effects and the best dose of anti-endoglin monoclonal antibody TRC105 when given together with bevacizumab and to see how well they work in treating patients with glioblastoma multiforme that has come back.
© 2015 Concord Hospital